IPO details · Updated
Pramodini Medicare Limited
- Price Band
- ₹110 – ₹118
- Lot Size
- 1,200 shares
- Min. Investment
- ₹1,41,600
- Issue Size
- ₹69.04 Cr
- Offer Dates
- 12 Aug – 14 Aug 2026
- Listing
- 19 Aug 2026
Issue Details
- Total Issue Size
- ₹69.04 Cr
- 58,51,200 shares
- Fresh Issue
- ₹63.14 Cr
- 53,50,800 shares
- Offer for Sale
- ₹5.9 Cr
- 5,00,400 shares
- Face Value
- ₹10 per share
- Issue Type
- Book-built IPO
- Listing At
- NSE SME
- Shares Pre-Issue
- 1,66,94,795
- Shares Post-Issue
- 2,20,45,595
IPO Timeline
Offer opens
12 Aug 2026
Offer closes
14 Aug 2026
Allotment
17 Aug 2026
Listing
19 Aug 2026
Issue Allocation
Share of the offer reserved for each investor category
- Anchor23.3%13,60,800 shares
- QIB20.0%11,71,200 shares
- HNI16.4%9,60,000 shares
- Retail34.6%20,23,200 shares
- MarketMaker5.7%3,36,000 shares
Subscription Status
Times subscribed by investor category
| Category | Offered | Bids | Subscribed |
|---|---|---|---|
| QIB | 11,71,200 | 42,86,592 | 3.66x |
| NII | 9,60,000 | 47,61,600 | 4.96x |
| Retail | 20,23,200 | 70,60,968 | 3.49x |
| Total | 41,54,400 | 1,61,09,160 | 3.88x |
Lot Size & Investment
1 lot = 1,200 shares
Retail (min)
2 lots · 2,400 shares
Retail (max)
2 lots · 2,400 shares
S-HNI (min)
3 lots · 3,600 shares
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 2 | 2,400 | ₹2,83,200 |
| Small HNI (S-HNI) | 3 | 3,600 | ₹4,24,800 |
| Big HNI (B-HNI) | 8 | 9,600 | ₹11,32,800 |
Financial Performance
Restated figures in ₹ crore, unless stated otherwise
| Period | Mar-26 | Mar-25 | Mar-24 |
|---|---|---|---|
| Assets | 93.62 | 56.45 | 48.78 |
| Total Income | 63.38 | 38.55 | 35.79 |
| Profit After Tax | 17.38 | 11.14 | 7.14 |
| EBITDA | 30.9 | 20.97 | 15.53 |
| Net Worth | 53.15 | 35.77 | 24.75 |
| Reserves & Surplus | 36.46 | 34.49 | 23.46 |
| Total Borrowing | 17.85 | 10.81 | 11.96 |
Key Performance Indicators
| Period | Mar-26 |
|---|---|
| ROE (%) | 39.08 |
| ROCE (%) | 34.66 |
| EPS (₹) | 10.41 |
| P/E (pre-issue) | 11.34 |
| P/E (post-issue) | 14.97 |
Peer Comparison
Listed companies in the same business
| Company | P/E | ROE |
|---|---|---|
| Invicta Diagnostic Ltd. | 13.62 | 9.76% |
| Krsnaa Diagnostics Ltd. | 16.74 | 10.35% |
| Star Imaging & Path Labs Ltd. | 7.87 | 16.58% |
About Pramodini Medicare Limited
Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities. Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour doppler, mammography, Dexa scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy. The company also operates a 24×7 teleradiology unit from Vijayawada and a processing laboratory at the same location. Service Model Public-Private Partnership (PPP): Operates diagnostic centres within government hospitals and medical colleges through long-term MOUs. Private-Private Partnership (Pvt-Pvt): Establishes and manages diagnostic centres inside private hospitals under partnership agreements. Strategic Partnerships with PSUs: Collaborates with Government of India PSUs to operate diagnostic and imaging centres across multiple states. Standalone Diagnostic Centres: Operates its own diagnostic centres and laboratories, serving both individual patients and hospitals. Location-Specific Agreements: Each diagnostic centre operates under separate MOUs or contracts with terms customized for the respective location. The business operates through four models: public-private partnership (PPP) with government hospitals and teaching institutions, private-private partnerships with hospitals, strategic partnerships with PSUs, and standalone private diagnostic centres. As of August 04, 2026, the company operated 16 diagnostic centres across seven states. As of March 31, 2026, the company had 161permanent employees. Competitive Strengths: Establishing a strategic presence across various states of India. Strengthening its network through diversified business models. Strong technical capabilities supported by robust IT infrastructure. Experienced management team with significant industry expertise. Consistent track record of revenue growth and financial performance. Diverse customer base, including hospitals, institutions, and individual patients.
Objects of the Issue
- Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres (₹45.15 Cr)
- General corporate purposes and unidentified inorganic acquisition (₹10.76 Cr)
- Issue Expenses (₹7.90 Cr)
Promoters
- <p>Chalasani Kuldeep Kumar
- Chalasani Kavitha
- Chalasani Durga Aashritha
- Chalasani Lalithakumar
- Sri Ram Medicare Pvt.Ltd.</p>
Company Information
- Book running lead managers
- Smart Horizon Capital Advisors Pvt.Ltd.
- Registered office
- D. No: - 29-4-54K, CSI Complex,, Prakasam Road,, Suryaraopet, Vijayawada, Andhra Pradesh, 520002
- Market maker
- Shreni Shares Ltd., Rainbow Securities Pvt.Ltd.
Official Documents
Opens the source filing in a new tab
Similar IPOs
Disclaimer: Data on OpenIPO is for information only and is not investment advice. OpenIPO is not a SEBI-registered entity. GMP figures are unofficial estimates and may change. Verify all details against the company RHP and the official registrar before investing.